Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Adeptus Health Inc ADPTQ

Healthcare Medical Care
"Adeptus Health Inc owns and operates First Choice Emergency Rooms, the network of independent freestanding emergency rooms in the United States."

Recent & Breaking News (GREY:ADPTQ)

Curebase, Adaptive Biotechnologies Announce Collaboration to Expand Clinical Study Access

PR Newswire August 10, 2021

Adaptive Biotechnologies Appoints Nitin Sood as Chief Commercial Officer

GlobeNewswire August 4, 2021

Adaptive Biotechnologies Reports Second Quarter 2021 Financial Results

GlobeNewswire August 4, 2021

Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021

GlobeNewswire July 12, 2021

New Study Published in Nature Provides Further Evidence that COVID-19 Vaccine Induced T-Cell Response Targets Known SARS-CoV-2 Variants of Concern

GlobeNewswire June 9, 2021

Adaptive Biotechnologies Included in More than 20 Abstracts at ASCO and EHA 2021 Highlighting Expanding Use Cases for MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients

GlobeNewswire June 3, 2021

Adaptive Biotechnologies to Participate in Upcoming June 2021 Investor Conferences

GlobeNewswire May 20, 2021

Adaptive Biotechnologies Reports First Quarter 2021 Financial Results

GlobeNewswire May 5, 2021

Adaptive Biotechnologies to Present at the BofA Securities 2021 Virtual Healthcare Conference

GlobeNewswire April 27, 2021

Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, 2021

GlobeNewswire April 12, 2021

Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Directors with Appointments of Leslie Trigg and Katey Owen

GlobeNewswire March 17, 2021

Adaptive Biotechnologies Announces FDA Emergency Use Authorization for T-Detect(TM) COVID to Confirm Recent or Prior COVID-19 Infection

GlobeNewswire March 5, 2021

Adaptive Biotechnologies to Present at the Cowen 41st Annual Healthcare Conference

GlobeNewswire February 25, 2021

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2020 Financial Results

GlobeNewswire February 24, 2021

Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio

GlobeNewswire February 23, 2021

Adaptive Biotechnologies Launches T-Detect(TM) COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection

GlobeNewswire February 23, 2021

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021

GlobeNewswire February 2, 2021

Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immune Response to Cancer Antigens to Potentially Inform the Development of Novel Diagnostics and Therapeutics

GlobeNewswire January 11, 2021

Adaptive Biotechnologies to Present at the 39th Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 30, 2020

Adaptive Biotechnologies Announces New Clinical Data Demonstrating Impact of clonoSEQ® Assay on Patients with Blood Cancers at the 62nd ASH Annual Meeting

GlobeNewswire December 6, 2020